In contrast, Boeckh-Behrens et al. demonstrated that AIS patients with an enrichment of CD31 + cells within the thrombus had better early regression, and CD31 was suggested as a potential neuroprotective agent for stroke patients [45]. This evidence concerns the gene PECAM1 and androgen insensitivity syndrome.